← Return to Brinsupri (aka Brensocatib)

Discussion
scoop avatar

Brinsupri (aka Brensocatib)

MAC & Bronchiectasis | Last Active: Feb 10 8:17am | Replies (164)

Comment receiving replies
Profile picture for lvnl @lvnl

@irenea8 just found this post from you by accident ... I am on Humira which treats a couple of autoimmune conditions. It is a specialty drug. It has kept me in remission for 7+ years. Just got a notice from my Aetna Medicare Advantage plan that they are taking it off their formulary for 2026 and suggesting we work with our doctors to transition to the "biosimilar" which came on the market a couple years ago at a fraction of the price. Humira is phenomenally expensive and I think I read it's one of the most profitable drugs in the world. My GI doctor's office had warned me that a lot of insurances are no longer covering it in 2026. So that's a long way of saying that yes, specialty drugs are being cut back. At least this one (Humira).

Jump to this post


Replies to "@irenea8 just found this post from you by accident ... I am on Humira which treats..."

@lvnl Here is a different viewpoint to consider.

Insurers and Medicare need to control costs when and where possible to avoid more premium increases. I know many people insurance companies believe are rich and can afford everything, but when I think about what my medical care and prescriptions cost, the $10,000 I pay in premiums and the $10,000 or so my employer contributes don't begin to cover the costs of my husband's & my care, even with the discounts the pharmacy benefit managers negotiate, and the limits Medicare places on charges.

Whenever there are generic or bio-equvalent drugs available we willingly try them. Nearly all have been fine and have saved both me and the company money. If they do not work after a reasonable trial, Blue Cross has made exceptions after sufficient documentation.

Similarly, when I wanted a faster nebulizer for my convenience, I didn't expect my insurance company to cover it. But, if I NEED it to dispense a specific drug, I'll fight for it.

Expensive specialty drugs like Brinsupri will need to demonstrate to insurers that they reduce primary medical expenses (like hospitalizations) in order to get onto their formularies or continue be covered.